PROCYON CORP (PCYN)
Procyon Corporation, along with its affiliated entities, specializes in the development and distribution of proprietary medical solutions. Their primary focus is on addressing various skin conditions, including pressure and stasis ulcers, general wounds, dermatitis, inflammation, and other dermatological issues, predominantly within the United States. The company offers a diverse array of products. Under the AMERIGEL brand, they provide sophisticated skin and wound healing items such as hydrogel dressings, post-operative surgical kits, saline wound rinses, and protective lotions, in addition to hand sanitizer. Their HELIX3 line features Bioactive Collagen products, available in both powder and matrix forms. For comprehensive wound management, the AMERX brand includes various dressing types like calcium alginate, foam, gauze, and hydrocolloid, as well as complete wound care kits containing components like collagen matrix, collagen powder, foam, and hydrogel. Furthermore, Procyon markets compression garments under the EXTREMIT-EASE name. These offerings are distributed through multiple channels: to institutional clients such as hospitals, wound care clinics, nursing homes, home health agencies, and medical practitioners via distributors, and directly to individual consumers through online sales, direct purchases, and independent or chain pharmacies. Founded in 1987, the company's operations are headquartered in Clearwater, Florida.
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Procyon Corporation
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
Procyon Corporation, along with its affiliated entities, specializes in the development and distribution of proprietary medical solutions. Their primary focus is on addressing various skin conditions, including pressure and stasis ulcers, general wounds, dermatitis, inflammation, and other dermatological issues, predominantly within the United States.
The company offers a diverse array of products. Under the AMERIGEL brand, they provide sophisticated skin and wound healing items such as hydrogel dressings, post-operative surgical kits, saline wound rinses, and protective lotions, in addition to hand sanitizer. Their HELIX3 line features Bioactive Collagen products, available in both powder and matrix forms. For comprehensive wound management, the AMERX brand includes various dressing types like calcium alginate, foam, gauze, and hydrocolloid, as well as complete wound care kits containing components like collagen matrix, collagen powder, foam, and hydrogel. Furthermore, Procyon markets compression garments under the EXTREMIT-EASE name. These offerings are distributed through multiple channels: to institutional clients such as hospitals, wound care clinics, nursing homes, home health agencies, and medical practitioners via distributors, and directly to individual consumers through online sales, direct purchases, and independent or chain pharmacies. Founded in 1987, the company's operations are headquartered in Clearwater, Florida.
Leadership
Fred W. Suggs, Jr.
Director
James B. Anderson
Chief Financial Officer & Director
Joseph R. Treshler
Director
Justice W. Anderson
Chief Executive Officer, President & Director
Employees
19
Country
US
Sector
Healthcare
Website
procyoncorp.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Grant/Award | 5.6K | $1.4K | Jul 31, 2024 | |
| Director | Grant/Award | 7.2K | $1.8K | Jul 31, 2024 | |
| Director | Grant/Award | 7.4K | $1.9K | Jul 31, 2024 | |
| Director | Grant/Award | 12.8K | $3.2K | Jul 31, 2024 |
| Name | Shares | % | Source |
|---|---|---|---|
Treshler Joseph Raymond Director | 7.4K | 0.1% | FORM 4 |
McCullough Monica Director | 7.2K | 0.1% | FORM 4 |
McComas Steven Director | 5.6K | 0.1% | FORM 4 |
Insiders
- McComas StevenDirector
- McCullough MonicaDirector
- Treshler Joseph RaymondDirector
- SUGGS FRED WILSON JRDirector
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
30d Avg
1.30K
60d Avg
1.84K
90d Avg
4.24K